Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Silvia Zheng"'
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 11, Pp 11942-11956 (2024)
Immune thrombocytopenia (ITP) is an autoimmune disease in which platelet autoantibodies play a significant role in its pathogenesis. Regulatory T cell dysfunction and T cell-mediated cytotoxicity also contribute to thrombocytopenia. Current therapies
Externí odkaz:
https://doaj.org/article/58c61a8f9d0a40448922e61f4bd2467c
Autor:
Shiying Silvia Zheng, Zohra Ahmadi, Halina Hoi Laam Leung, Rose Wong, Feng Yan, Jose Sail Perdomo, Beng Hock Chong
Publikováno v:
Haematologica, Vol 107, Iss 9 (2022)
Immune thrombocytopenia (ITP) is a bleeding disorder caused by dysregulated B- and T- cell functions, which lead to platelet destruction. A well-recognized mechanism of ITP pathogenesis involves anti-platelet and anti-megakaryocyte antibodies recogni
Externí odkaz:
https://doaj.org/article/3e31b76681374fe6bae34b8df66e6331
Autor:
Vanessa Verissimo, Tina Carter, Helen Wright, Jeremy Robertson, Michael Osborn, Peter Bradbeer, Vanaja Sabesan, Ben Saxon, Pasquale Barbaro, Gemma Crighton, Janis Chamberlain, Silvia Zheng, Kate Freeman
Publikováno v:
Journal of Paediatrics and Child Health. 59:711-717
Autor:
Xiaoyi Fang, Mo Yang, Shiying Silvia Zheng, Yingyun Fu, Liang Li, Shichao Chen, Hongwu Xin, Beng H. Chong, Bihui Huang, Chun Chen, Chenju Yi, Liuming Yang, Junyan Zhong, WenJie Xia
Publikováno v:
Aging (Albany NY)
Thrombopoietin (TPO) is a growth factor for the megakaryocytic/platelet lineage. In this study, we investigated the expression of TPO and its receptor, c-Mpl, in the human central nervous system (CNS) and their roles after a neural insult. Our result
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 18(3)
Background The notable discrepancy between platelet count and bleeding manifestations in immune thrombocytopenia (ITP) patients with acquired Glanzmann thrombasthenia (GT) has been described. Objectives We aimed to examine the mechanisms responsible
Publikováno v:
Expert opinion on drug metabolismtoxicology. 12(5)
Venous thromboembolism (VTE) is a common disorder. Heparin and vitamin K antagonists have been the standard treatment for VTE for over 50 years. The development of apixaban and other direct oral anticoagulants has greatly increased the range of antic
Autor:
Tim Brighton, Shiying Silvia Zheng
Publikováno v:
Pathology. 48:S36